Two Sigma Advisers’s Celgene Corp CELG Stock Holding History

Two Sigma Advisers’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-24,000	Closed	-$2.27M	–	3027
2014 Q3	$2.27M	Sell	24,000 -63,000	-72%	-$5.69M	0.02%	768
2014 Q2	$7.47M	Buy	87,000 +83,000	+2,075%	+$6.31M	0.06%	356
2014 Q1	$279K	Buy	+4,000	New	+$317K	﹤0.01%	1920
2013 Q4	–	Sell	-22,000	Closed	-$1.69M	–	2696
2013 Q3	$1.69M	Buy	22,000 +12,000	+120%	+$841K	0.02%	706
2013 Q2	$585K	Buy	+10,000	New	+$602K	0.01%	1219

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Two Sigma Advisers's CELG Position: Q4 2019 in Review

Two Sigma Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 644,726 shares — an estimated $64M sold.

Two Sigma Advisers first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $327M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Two Sigma Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Two Sigma Advisers sold 644,726 Celgene Corp shares in Q4 2019, an estimated $64M.
Two Sigma Advisers first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
Two Sigma Advisers's Celgene Corp position peaked at $327M in Q4 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.